Dipna Pharmachem Ltd — Others, 08-08-2025: AGM/EGM

Dipna Pharmachem has released its Annual Report for FY25 and announced an upcoming Annual General Meeting. The report includes audited financial results for FY25, showing revenue of Rs. 124.93 Cr, profit before tax of Rs. 1.42 Cr, and net profit of Rs. 0.97 Cr. Shareholders will vote on approving significant related party transactions up to Rs. 100 Cr with three entities, aimed at leveraging specialized expertise and enhancing operational efficiency. The company also proposes increasing its authorized share capital to Rs. 25.50 Cr for future business prospects. No dividend is proposed, as the company plans to conserve resources for growth. The board is also seeking approval for director appointments.